Cochrane Abstracts
Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Daratumumab and Antineoplastic Therapy Versus Antineoplastic Therapy Only for Adults With Newly Diagnosed Multiple Myeloma Ineligible for Transplant." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_adults_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant.
Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_adults_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant. Accessed January 15, 2025.
Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_adults_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant
Daratumumab and Antineoplastic Therapy Versus Antineoplastic Therapy Only for Adults With Newly Diagnosed Multiple Myeloma Ineligible for Transplant [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_adults_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant
ID - 436447
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436447/all/Daratumumab_and_antineoplastic_therapy_versus_antineoplastic_therapy_only_for_adults_with_newly_diagnosed_multiple_myeloma_ineligible_for_transplant
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
